Yu-Li Lo
8PUBLICATIONS
5CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Nov 27, 2025
Functional pH-Responsive Nanoparticles for Immune Reprogramming in MSS Colorectal Cancer via ER Stress-Induced Proteostasis Disruption, PD-L1-Targeting miRNA, and TLR7 Activation.Yu-Li Lo, Hua-Ching Lin, Ching-Yao Li
|Nov 01, 2024
Modulating versatile pathways using a cleavable PEG shell and EGFR-targeted nanoparticles to deliver CRISPR-Cas9 and docetaxel for triple-negative breast cancer inhibition.Yu-Li Lo, Ci-Jheng Hong, Chen-Shen Wang
|Oct 27, 2022
Implication of Adipogenesis-Coupled CRMP2 Functional Profile in Metabolic Homeostasis and Imbalance.Yih-Hsin Chang, Shu-Wen Chang, Wei-Ting Hsu
|Sep 23, 2022
Two-in-One Nanoparticle Formulation to Deliver a Tyrosine Kinase Inhibitor and microRNA for Targeting Metabolic Reprogramming and Mitochondrial Dysfunction in Gastric Cancer.Yu-Li Lo, Tse-Yuan Wang, Chun-Jung Chen
|Aug 16, 2020
Mitochondrion-Directed Nanoparticles Loaded with a Natural Compound and a microRNA for Promoting Cancer Cell Death via the Modulation of Tumor Metabolism and Mitochondrial Dynamics.Yu-Li Lo, Chen-Shen Wang, Yen-Chun Chen
|Nov 12, 2019
pH-Responsive PEG-Shedding and Targeting Peptide-Modified Nanoparticles for Dual-Delivery of Irinotecan and microRNA to Enhance Tumor-Specific Therapy.Vivian Juang, Chih-Hsien Chang, Chen-Shen Wang
Pageof 2
